drugset / Trial / NCT00641693
Assess the Efficacy and Safety of Rhinocort Aqua
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare Rhinocort with placebo in pediatric subjects aged 2-5 years with allergic rhinitis to study effects on nasal symptoms such as sneezing, runny and stuffy noses.
Timeline
- Start
- 2004-04
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 16 mg | Intranasal |
| Subject | Budesonide | Small molecule | 32 mg | Intranasal |
| Subject | Budesonide | Small molecule | 64 mg | Intranasal |